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Abstract
Aplasia cutis congenital (ACC) in lower legs is a rare disease with the absence
of the skin, which commonly localized, widespread or scarred at birth. The exact
pathophysiology remains unclear, and varicella infection may have essential roles in
the aetiologies. Wound healing can be accelerated by using Human Dermal Papillae
Conditioned Medium (HDPCM) which has multi-lineage potential differentiation and
releases many growth factors. This paper reports the possibility of using human dermal
papillae conditioned media to speed up the wound healing process. A 4 days old
baby boy presented with ulcers on his both knees since birth and had no history of
birth trauma. The mother had varicella infection during the 2𝑛𝑑-trimester of pregnancy.
From the dermatological examination, we found defects and total skin loss on both
knees. The result of the serology test showed the persistence of varicella-zoster virus
immunoglobulin in both patient and his mother. The result of histopathological test
supported the diagnosis of ACC. The patient was given topical therapy using 0.1 ml
of HDPCM and 10 gr of water-based antioxidant gel and showed improvement after
ten days of administration. Evaluation of a patient with ACC by the detailed history
and examination could determine varicella as the etiology of the disease. Furthermore,
work-up should be based on symptoms and clinical findings. The HDPCM contributes
to neovascularization and tissue maturation which in turn could reduce inflammation,
resulting in a better healing process with less scar and wound contraction, thus hasten
the healing process. We conclude that the HDPCM can be used to accelerate the
wound healing process in ACC due to varicella infection.
Keywords: Aplasia cutis congenital, Human Dermal Papillae, Conditioned Media,
Varicella
1. Introduction
Aplasia cutis congenital (ACC) is a rare malformation that is characterized by the total
absence of all layers of skin at birth. The lesion commonly presents on the scalp, but
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several studies reported the lesion was on the trunk and extremities. After birth, the
diagnosis of ACC is determined from the clinical and histologic examination.
Until now, no embryologic theory supports the etiology of ACC [1, 2] and the patho-
physiology of ACC is not clear. Though genetic factor plays an essential role in ACC,
other factors may contribute and are responsible for the mechanism. These factors
included intrauterine trauma, local amniotic adhesions, and exposure to varicella and
herpes simplex infection. The teratogenic agents, for example, antithyroid drugs, val-
proic acid, marijuana, heroin, alcohol, and cocaine may contribute to ACC [3]. The
condition also may be associated with abnormalities of chromosomal, ectodermal
dysplasias, epidermolysis bullosa, specific teratogens, intrauterine infections, or other
malformation syndromes like Adams-Oliver syndrome, SCALP syndrome (nevus seba-
ceous, central nervous system [CNS] malformations, aplasia cutis congenital, lumbal
dermoid, pigmented nevus) and Opitz syndrome [3, 4]. The incidence of varicella in
pregnancy remains unclear although infection may lead to severe illness in pregnancy
and may associate with transplacental virus transmission and fetal infection.
The treatment of ACC remains a dilemma with no agreement upon methods. Both
conservative and surgical approaches to the early management of tissue defects have
been reported, with varying results [2, 5, 6]. There were 4 cases of ACC reported in the
literature, the cases were caused by varicella infection in the first and second trimester
of the pregnancies. The last case was reported by Gupta et al. in 2014 where the lesion
appeared on the thigh to the knee of the twin [7, 8]. Management of ACC is using conser-
vative, surgical or a combination of both. Conservative treatment for small ACC lesions
using petrolatum, silver sulfadiazine or bacitracin aimed to give rise to granulation and
healing with scars [2, 5]. Shirvany et al. reported that ACC repair using mupirocin took
about two months, and in cases with no scalp wounds, the healing process took 38 days
[4, 9]. The use of acellular dermal graft and cultured epithelial autograft has also been
reported with full repair in 7 to 14 days [6].
The HDPCM is a secretion factor of stem cells obtained from dermal papilla cultures.
The dermal papillae have the most stem cells compared to other hair parts. The use
of HDPCM has been widely reported to accelerate wound healing in the presence of
various growth factors that contribute to wound healing. These growth factors include
insulin-like growth factor-I (IGF-I), hepatocyte growth factor (HGF), vascular endothelial
growth factor (VEGF) and TGF-β1 [10]. The use of HDPCM in the ACC case has never
been reported before.We report the use of HDPCM in the ACC casewhichwas expected
to accelerate wound healing.
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2. Case and Methods
A four-day-old baby boy was born from a 28-year woman with 35 weeks of pregnancy.
He was delivered vaginally with the body weight of 2900 gram. The infant was born
with the absence of the skin congenitally that involved both knee and upper thighs. The
skin lesions revealed a thin translucent membrane covered the skin defect and dermal
vessels were easily visible. The wound tended to exude with serous fluid and distributed
symmetrical and bilateral. The healthy skin surrounding the wound appeared dry and
scaling (Fig.1). No drugs were consumed during the mother’s pregnancy and the baby
had a non-consanguineous father. His mother suffered from varicella during the second
trimester of pregnancy.
On physical examination, the neonate had a skin defect on both knees with the size of
2x2 cm and 3x1cm and had inflammation surrounding the ulcers. On laboratory examina-
tion, serologic results revealed high titers of varicella-zoster virus (VSV) immunoglobulin
(IgG) 2.08 in the baby and 2.79 in his mother; those results were three times higher
than reference and were interpreted as positive detection of VZV IgG. There were no
abnormalities in babygram and thorax radiology. The radiologic examination of extrem-
ities showed soft tissue swelling, no bone deformities with a blastic and lytic lesion. The
histologic examination demonstrated vacuolar degeneration and rete-ridges flattening,
an absence of adnexal structures, edema of dermis and dilatation of vasculature, thus
confirmed the ACC group VII according to Frieden’s clinical classification. The affected
areas were given 0.1 ml of HDPCM and 10 gr of water-based antioxidant gel; then the
wounds were dressed exclusively. The dressings were changed regularly every three
days. On day 10, the defect closed completely.
2.1. Topical HDPCM
The isolation of dermal papillae stem cells was carried out by cutting 3x3 mm2 of dermis
tissue, incubated at 1:1 PBS, and disposed at 4 ∘C for 16-18 hours. After cell suspen-
sion and neutralization with complete media, then the cells were cultured in a 60 mm
Petri with an entire culture medium. Cells subculture was then carried out with warm
trypsinisation techniques using EDTA trypsin 0.25%. Media from confluent cell cultures
were then discarded and washed with PBS for 2x. Cells that were released from Petri
culture were neutralized with complete media as much as 2x the volume of trypsin and
after centrifugation, they are re-cultured in complete media or kept frozen until used for
treatment. The characteristics of hair bulge stem cells were evaluated using the flow
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cytometry method using anti CD59 and CD 200 antibodies according to the protocol
recommended by BD.
Conditioned dermal papilla media is produced to induce folliculogenesis by improving
the niche in the environment in which the dermal papilla as a supporter of hair follicles.
The technique used to stimulate the secretion of bioactive metabolites from cell cultures
is a three-dimensional culture technique using fibrin gel coating on Petri culture. Twenty
hours after incubation, the media was collected and filtered with a 0.45 μm Millipore
filter then stored at -80 ∘C until ready for use. Ten grams of antioxidant gel were used as
DP-CM carriers and applied directly to the wound area.
 
   
   
 
Figure 1: Day 0. Skin defect on the right and left knee, then given topical HDPCM.
Figure 2: Day 10. Evaluation of the lesion showing a complete closure after ten-day administration of
HDPCM.
3. Discussion
Ulceration in newborns can be associated with several conditions, and one of them
is ACC [9]. Aplasia cutis congenital is a rare congenital condition [2] in the absence
of skin, most often involving the epidermis and dermis [11] and in some cases involve
subcutan area [9]; which usually occurs in a localized or wide area, or appears as scar
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at birth [11]. Cutaneous aplasia can occur as an isolated defect, associated with other
developmental abnormalities, or as a description of various abnormalities. There is no
single underlying cause in the occurrence of ACC which shows the physical findings
of intrauterine skin development abnormalities. Other etiologies may include genetic
factors, vascular disorders, trauma, teratogens, and intrauterine infections [11].
About 15% of ACC lesions occur in the trunk and extremities [12] and are generally
bilateral and symmetrical. However, asymmetrical distribution has been reported [9].
Defects involving the trunk and extremities often have more extensive lesions than the
scalp, but have a better prognosis and tend to heal faster [12]. Cutaneous congenital
aplasia in the lower extremities is a rare disorder [11].
Varicella-zoster virus can induce various forms of diseases, from mild to severe and
can be treated satisfactorily. In pregnancy, this virus can also affect the mother and
fetus, causing maternal, fetal and neonatal abnormalities [13]. Vertical transmission can
be detected using polymerase chain reaction (PCR) before the 24th week of pregnancy
in 24 and 8% of varicella cases. Varicella in pregnancy can cause spontaneous preterm
birth, low birth weight, intrauterine growth restriction, congenital varicella syndrome or
maternal varicella pneumonia and varicella in neonates [14].
From history taking, we were informed that the mother of our present patient had a
history of varicella at the second trimester of pregnancy and is supported by the positive
results of VZV IgG in the patient and the mother. The primary factor in the occurrence of
ACC from this patient is a history of varicella infection intrauterine (during pregnancy).
The treatments for ACC are reported using conservative and surgical tissue defects.
ACC skin lesions often heal gradually and leave hypertrophic or atrophic scars (Figure
1 and 2), skin contractures, and hypopigmentation or hyperpigmentation. Healing can
occur spontaneously through granulation and re-epithelialization from the edges of the
normal skin [2]. Handling for small ACC lesions tends to be conservative, including
local wound care that will cause granulation and scar healing [3]. Local wound care
is recommended for small lesions of less than 3 cm2. The advantage of conservative
treatment is to avoid the risk of surgery in newborns [15]. An earlier repair surgery [13] is
recommended for extensive skin defects or if the defects affecting the bone [5]. Radi-
ological examination before surgery is needed to identify the structure of the blood
vessels underlying the lesion [11]. Surgical revision for scarring that appears later in
childhood or adulthood can be done electively for cosmetic improvement [14].
Eurocat, an institution that collects statistical data on congenital abnormalities
throughout the world, classifies ACC as a congenital skin disorder and has a total of
177 cases of ACC registered in Poland in 1999-2009. The Polish Registry of Congenital
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Malformations has collected data on 168 cases of AKK that occurred in the area surveyed
in 1998-2008; 2 cases included ACC with defects in the lower extremities. Aplasia cutis
congenita of the extremities is characterized by the loss of skin with well-defined lesions,
most often involving the epidermis and dermis. These well-defined lesions can involve
muscles and bones. Lesions can be ulcerated, with a smooth pink surface where the
epidermal is lost or reduced. The dermis, if present, is thin and has no appendages.
Lesions are usually small, about 0.5-3 cm in diameter [15].
In recent years, many efforts have beenmade to enhance the progress andmodalities
of wound therapy, including the stem cells and its growth factors [16]. The use of Mes-
enchymal Stem Cells (MSCs) is a new approach to the treatment of wounds, especially
chronic wounds [17]. MSCs have their characteristics such as the ability to self-renew
and have the ability to differentiate into various types of tissue with asymmetric replica-
tion into complex structures such as osteoblasts, adipocytes, chondrocytes, tenocytes,
myocytes and epithelialization of the skin. Many sources of stem cells can be used to
modulate wound healing responses in acute and chronic disease, such as bone marrow,
cord blood, adipose tissue, skin and hair follicles [16, 18].
One of MSC populations on the skin is dermal papillae (DP), which is a stem cell with
multilineage differentiation potential. The role of DP is known not only to regulate the
development and growth of hair follicles but also considered as a reservoir multipotent
stem cells that have the potential to differentiate into various types of cells that have
important therapeutic potential. In the hair growth cycle, the role of DP begins at post-
natal where hair follicles grow in several phases, resting or telogen phases, growth or
anagen phases and regression phases or pathogens. During the catagen phase, the
epithelial cells at the base of the follicle undergo apoptosis, but the DP remains intact
and will migrate upwards until it ends at the bulb stem hair follicle. This situation contin-
ues during the telogen phase. In the anagen phase, DP cells at the base of the follicle
begin to multiply, which results in the downward growth of the follicles and closure of
the DP [19].
Meanwhile for wound healing, in vitro experiments reported that the use of DP stem
cells for wound healing showed good results, the result seen from good wound healing
without scarring and minimal wound contraction, good neovascularization and short-
ened inflammation time. The beneficial result is because the dermal papilla has various
growth factors that contribute to the healing process of the wound [10]. Some of these
growth factors include insulin-like growth factor-I (IGF-I), hepatocyte growth factor (HGF),
VEGF and TGF-β1 [20].
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4. Conclusion
We reported the case of aplasia cutis congenita, which involved both knees. There was
the absence of the skin, and the surrounding skin appeared redness. The lesion was
managed with topical HDPCM and the wounds closed completely in ten days.
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